Revenues (Tables)

3 Months Ended

Mar. 31, 2025

Revenues [Abstract]

Revenues

During the three months ended March 31, 2025 and 2024, our revenues were comprised of the following (in thousands):

	Three Months Ended March 31,
	2025		2024
Revenue:
Commercial revenue:
Product sales, net:
TRYNGOLZA sales, net	$	6,287	$	—
Total product sales, net		6,287		—
Royalty revenue:
SPINRAZA royalties		48,010		38,455
WAINUA royalties		9,372		1,125
Other royalties		6,784		9,805
Total royalty revenue		64,166		49,385
Other commercial revenue:
TEGSEDI and WAYLIVRA revenue, net		5,715		8,628
Other revenue		—		1,580
Total other commercial revenue		5,715		10,208
Total commercial revenue		76,168		59,593
Research and development revenue:
Collaborative agreement revenue		45,031		49,345
WAINUA joint development revenue		10,413		10,559
Total research and development revenue		55,444		59,904
Total revenue	$	131,612	$	119,497